Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

ZETA GLOBAL HOLDINGS CORP. (ZETA)

  • Business News
  • June 01, 2026, 20:05 UTC
  • 7
  • 1 comments

Zeta Global Announces Olympic Gold Medalist, Entrepreneur and Founder Lindsey Vonn as Second Zeta Live 2026 Keynote Speaker

Market reaction Comment Full text

CANDEL THERAPEUTICS, INC. (CADL)

  • Business News
  • June 01, 2026, 20:05 UTC
  • 8
  • 1 comments

Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Market reaction Comment Full text

8X8 INC /DE/ (EGHT)

  • Business News
  • June 01, 2026, 20:05 UTC
  • 2
  • 1 comments

8x8, Inc. Announces Participation in Evercore Global TMT Conference

Market reaction Comment Full text

DAVE & BUSTER''S ENTERTAINMENT, INC. (PLAY)

  • Business News
  • June 01, 2026, 20:05 UTC
  • 6
  • 1 comments

Dave & Buster’s Entertainment, Inc. to Report First Quarter 2026 Financial Results on June 15, 2026

Market reaction Comment Full text

HEIDMAR MARITIME HOLDINGS CORP. (HMR)

  • Business News
  • June 01, 2026, 20:05 UTC
  • 5
  • 1 comments

Heidmar Maritime Holdings Corp. Announces Transition in Chief Financial Officer Role

Market reaction Comment Full text

KARYOPHARM THERAPEUTICS INC. (KPTI)

  • Business News
  • June 01, 2026, 20:05 UTC
  • 5
  • 1 comments

Karyopharm Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Market reaction Comment Full text

CURBLINE PROPERTIES CORP. (CURB)

  • Business News
  • June 01, 2026, 20:05 UTC
  • 4
  • 1 comments

Curbline Properties Second Quarter 2026 Investment and Capital Markets Update

Market reaction Comment Full text

SERA PROGNOSTICS, INC. (SERA)

  • Business News
  • June 01, 2026, 20:05 UTC
  • 5
  • 1 comments

SERA PROGNOSTICS ANNOUNCES BOARD TRANSITION

Market reaction Comment Full text

AKEBIA THERAPEUTICS, INC. (AKBA)

  • Business News
  • June 01, 2026, 20:05 UTC
  • 2
  • 1 comments

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Market reaction Comment Full text

ABIVAX S.A. (ABVX)

  • Business News
  • June 01, 2026, 20:05 UTC
  • 5
  • 1 comments

Abivax Announces Landmark Phase 3 ABTECT Maintenance Trial Results Evaluating Obefazimod in Moderately to Severely Active Ulcerative Colitis

Market reaction Comment Full text
  • Previous
  • 1016
  • 1017
  • 1018
  • 1019
  • 1020
  • Next

Search

News categories

  • Technical Exchange News(13264)
  • Event(6229)
  • SEC News(337279)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(187273)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin